Search results

From WikiMD.com Medical Encyclopedia

  • {{short description|Pharmaceutical company}} ...ly founded in Norway and became known for its innovative approaches in the pharmaceutical industry.
    2 KB (319 words) - 03:55, 13 February 2025
  • ...sachusetts]], United States. Shire was acquired by [[Takeda Pharmaceutical Company]] in January 2019, in a deal valued at $62 billion, making it one of the la ...ence. Notable acquisitions included the purchase of [[Baxalta]] in 2016, a company specializing in hematology, immunology, and oncology, which significantly b
    3 KB (354 words) - 17:29, 26 March 2024
  • ...iption|An overview of Takeda Oncology, a division of Takeda Pharmaceutical Company Limited}} [[File:40_landsdowne.jpg|thumb|right|Takeda Oncology headquarters at 40 Landsdowne Street, Cambridge, Massachusetts]]
    3 KB (384 words) - 14:23, 21 February 2025
  • ...and [[hereditary angioedema]]. Shire was acquired by Takeda Pharmaceutical Company in January 2019. ...es in Shire's history include the acquisition of [[Richwood Pharmaceutical Company]] in 1997, which brought the ADHD medication Adderall into its product line
    3 KB (456 words) - 01:20, 20 February 2025
  • ...pharmaceutical giant, in a deal valued at $62 billion, marking one of the pharmaceutical industry's largest acquisitions. ...loping and selling supplements for [[hypothyroidism]]. Over the years, the company expanded its focus to include a broader range of medical conditions, partic
    3 KB (427 words) - 03:41, 30 March 2024
  • ..., development, and commercialization of medicines for cancer patients. The company was known for its work in developing targeted therapies for rare and diffic ...headquartered in [[Cambridge, Massachusetts]], a hub for biotechnology and pharmaceutical research. Over the years, ARIAD developed a number of innovative therapies,
    3 KB (413 words) - 21:53, 16 February 2025
  • BY-oh-LAH-jik AY-jent. * '''[[Vaccines]]''': Biological preparations that provide acquired immunity to a particular disease, containing agents that resemble a disease
    67 KB (8,469 words) - 20:42, 12 March 2024